Dr. Senthil Nathan Jayarajan, MD

Dr. Jayarajan practices at Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health.

Dr. Jayarajan's NPI, 1831359983, was assigned on June 12, 2008. Dr. Jayarajan graduated from Michigan College of Medicine and Surgery in 2008. Dr. Jayarajan holds Minnesota license 65103.

Dr. Jayarajan's primary practice is Abbott Northwestern Hospital, at 800 East 28th Street, Minneapolis, MN 55407 in Hennepin County. The practice phone is (612) 863-4000.

Dr. Jayarajan's primary practice is Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health. Dr. Jayarajan is also affiliated with United Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Jayarajan to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jayarajan practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Jayarajan's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Jayarajan's licenses on file in 2 states: Minnesota and Missouri.

CMS data shows 427 Medicare services from Dr. Jayarajan across 11 procedure codes in 2024, for 366 Medicare patients. Medicare paid $25,128 for them.

CMS counts 366 Medicare patients who saw Dr. Jayarajan in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jayarajan's median patient age at 72, with 47% women.

In 2024, Dr. Jayarajan wrote 78 Medicare Part D claims for 26 patients. 94% of them were for generic drugs. CMS names the drug for 55 of them, across 2 drugs with 11 or more claims each, at $990 in total drug cost. In 2023, CMS named 39 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Jayarajan for performance year 2024, reported as part of a group. Dr. Jayarajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jayarajan as offering telehealth. CMS counts 15 procedures of leg revascularization (restoring blood flow) by Dr. Jayarajan, more than 72% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 52 papers to Dr. Jayarajan, published from 2010 to 2022. 2013 was the busiest year, with 7. The most frequent topics are Heart Transplantation, Length of Stay and Heart-Assist Devices. Dr. Jayarajan has published most often in Ann Vasc Surg. Dr. Jayarajan's most frequent co-authors are Yoshiya Toyoda, MD, PhD, Thomas Santora, MD and Abeel A. Mangi, MD.

CMS Open Payments shows 17 general payments to Dr. Jayarajan from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. Silk Road Medical, Inc. paid the most, $1,290.

Dr. Jayarajan graduated from Michigan College of Medicine and Surgery in 2008.